---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-24-000043"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:32:54.855906+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare reports Q2 2024: flat revenue, margin expansion, updates guidance

## Summary
- Revenue flat at $4.8B; organic revenue grew 1% YoY; net income margin improved to 8.9% from 8.7%.
- Adjusted EBIT margin expanded to 15.3% (up 60 bps); adjusted EPS rose to $1.00 from $0.92.
- Full-year organic revenue growth guidance lowered to 1-2% (from ~4%) due to China headwinds; adjusted EBIT margin guidance raised to 15.7-16.0%.
- Cash flow from operations was -$119M vs -$67M; free cash flow -$182M vs -$136M.

## SEC filing metadata
- accession: 0001932393-24-000043
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000043/0001932393-24-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000043/gehc-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-24-000043
- JSON: https://secwatch.observer/filing/0001932393-24-000043.json
- Plain text: https://secwatch.observer/filing/0001932393-24-000043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.